To determine if increased CD103+ DCs are dependent on elevated GM-CSF in RaptorECKO mice, LLC tumors were implanted into tamoxifen-treated mice, and the tumor-bearing mice were treated with GM-CSF neutralizing antibodies or isotype-matched control IgG (Figure 6G). This evidence concerns the gene CSF2 and neoplasm.